Prostate Cancer Clinical Trial
Official title:
Could Urinary Bladder Hypertrophy Influence on Urge Urine Incontinence Development in Patients After Radical Prostatectomy: A Multi-center Study
This study is designed to evaluate men before radical prostatectomy for the incidence of Overactive Bladder (OAB), as well as urge urine incontinence (UUI) development after the surgery. Patients will be evaluated for signs of OAB and for signs of Bladder Outlet Obstruction (BOO). Afterwards they will be divided into four observational groups. Follow up period is designed to be 12 months.
Radical prostatectomy remains the standard treatment in case of organ-confined and in
selected cases of locally advanced prostate cancer. Radical prostatectomy consists of
removing the prostate gland and seminal vesicles, ideally with negative surgical margins.
Most of the patients who present urinary incontinence after radical prostatectomy have
stress urinary incontinence. However in some cases the post-surgical urinary incontinence is
also due to urgency caused by overactive bladder development defined as urge urinary
incontinence. Recent clinical observations suggest that men can also develop overactive
bladder after radical prostatectomy.
This study is designed to evaluate men before radical prostatectomy for the incidence of
Overactive Bladder (OAB) and it's development after the surgery. Before surgery
questionnaire assessment of lower urinary tract symptoms will be performed using
International Prostate Symptom Score (IPSS) questionnaire. OAB symptoms will be analyzed
using King's questionnaire, as well as using two different OAB symptom score (OABSS)
designed by Blavis et al. and Homma et al. Each patient will have transabdominal
ultrasonographic evaluation of the prostate and urinary bladder structure. Prostatic
dimensions width (W), height (H), length (L) and volume will be recorded. The
ultrasonography will be done in urinary bladder filling related to normal desire to void.
Urinary bladder wall thickness (BWT) and detrusor muscle thickness (DWT) will be measured in
sagittal plane in anterior bladder wall. The mean of three following measurements BWT and
DWT will be obtained. The urinary bladder weight (UEBW: Ultrasound Estimated Bladder Weight)
will be also estimated. After ultrasonography each patient will undergo uroflowmetry with
post-void residual estimation.
On the results above 4 groups will be formed
Group 1 OAB (-) BOO (-)
Group 2 OAB (-) BOO (+)
Group 3 OAB (+) BOO (+)
Group 4 OAB (+) BOO (-)
The investigators will obtain detail information about the surgery (time, blood loss,
histopathological outcome, nerve sparing, complications).
After the initial evaluation of the patients before surgery, the control evaluation is set
on 1, 3, 6, 9, and 12 month after radical prostatectomy in groups 1-4 to define the lower
urinary tract symptoms after radical prostatectomy related to pre-surgical patient clinical
feature. During each of the following controls the investigator will not have the access to
previously obtained data from the patient.
In addition, healthy volunteers aged 20 to 40 will be assigned as a control group.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |